Loading...
Masimo Corporation
MASI•NASDAQ
Healthcare
Medical - Instruments & Supplies
$164.62
$3.24(2.008%)
Masimo Corporation (MASI) Financial Performance & Income Statement Overview
Review Masimo Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.26%
↑ 2.26%
Operating Income Growth
-295.38%
↓ 295.38%
Net Income Growth
-474.11%
↓ 474.11%
Operating Cash Flow Growth
108.71%
↑ 108.71%
Operating Margin
-11.28%
↓ 11.28%
Gross Margin
50.50%
↑ 50.50%
Net Profit Margin
-25.06%
↓ 25.06%
ROE
-40.95%
↓ 40.95%
ROIC
-12.74%
↓ 12.74%
Masimo Corporation (MASI) Income Statement & Financial Overview
Review Masimo Corporation's (MASI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $600.70M | $504.60M | $496.30M | $492.80M |
| Cost of Revenue | $356.00M | $241.40M | $241.50M | $251.10M |
| Gross Profit | $244.70M | $263.20M | $254.80M | $241.70M |
| Gross Profit Ratio | $0.41 | $0.52 | $0.51 | $0.49 |
| R&D Expenses | $77.70M | $48.30M | $49.00M | $47.80M |
| SG&A Expenses | $221.60M | $184.80M | $177.50M | $159.90M |
| Operating Expenses | $603.80M | $233.10M | $226.50M | $207.70M |
| Total Costs & Expenses | $655.20M | $474.50M | $468.00M | $458.80M |
| Interest Income | $1.10M | $1.30M | $1.20M | $1.20M |
| Interest Expense | $10.00M | $10.50M | $11.00M | $12.00M |
| Depreciation & Amortization | $30.80M | $24.00M | $23.90M | $24.30M |
| EBITDA | -$320.90M | $46.10M | $52.20M | $59.30M |
| EBITDA Ratio | -$0.53 | $0.09 | $0.11 | $0.12 |
| Operating Income | -$359.00M | $30.10M | $28.30M | $34.00M |
| Operating Income Ratio | -$0.60 | $0.06 | $0.06 | $0.07 |
| Other Income/Expenses (Net) | -$2.70M | -$18.50M | -$8.40M | -$9.10M |
| Income Before Tax | -$361.70M | $11.60M | $19.90M | $24.90M |
| Income Before Tax Ratio | -$0.60 | $0.02 | $0.04 | $0.05 |
| Income Tax Expense | -$12.10M | $1.80M | $3.90M | $6.00M |
| Net Income | -$349.60M | $9.80M | $16.00M | $18.90M |
| Net Income Ratio | -$0.58 | $0.02 | $0.03 | $0.04 |
| EPS | -$6.52 | $0.18 | $0.30 | $0.36 |
| Diluted EPS | -$6.52 | $0.18 | $0.29 | $0.35 |
| Weighted Avg Shares Outstanding | $53.60M | $53.40M | $53.10M | $53.00M |
| Weighted Avg Shares Outstanding (Diluted) | $53.60M | $54.30M | $54.30M | $54.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan